MX2010009578A - Metodos para incrementar el espesor epidermico de la piel mediante la administracion topica de un compuesto de vitamina d que contiene 19-nor. - Google Patents
Metodos para incrementar el espesor epidermico de la piel mediante la administracion topica de un compuesto de vitamina d que contiene 19-nor.Info
- Publication number
- MX2010009578A MX2010009578A MX2010009578A MX2010009578A MX2010009578A MX 2010009578 A MX2010009578 A MX 2010009578A MX 2010009578 A MX2010009578 A MX 2010009578A MX 2010009578 A MX2010009578 A MX 2010009578A MX 2010009578 A MX2010009578 A MX 2010009578A
- Authority
- MX
- Mexico
- Prior art keywords
- methylene
- hydroxy
- vitamin
- methods
- dihydroxyvitamin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Métodos para incrementar el espesor de la capa epidérmica en la piel de un humano, que comprenden administrar tópicamente una dosis terapéuticamente efectiva de un ingrediente farmacéutico, activo que comprende un análogo de vitamina D que incluye 2-metilen-19-nor-20(S)-1a-hidroxi-bishomopregnacalciferol, 19-nor-26,27-dimetilen-20(S)-2-metilen-1a,25-dihidroxivitamina D3, 2-metilen-19-nor(24R)-1a, 25-dihidroxivitamia D2, 2-metilen-1a, 25-dihidroxi-(17E)-17(20)-deshidro-19-nor-vitamina D3, 2-metilen-(20R,25S)-19,26-dinor-1a,25-dihidroxivitamina D3, 2-metilen-18,19-dinor-(20S)-1a,25-dihidroxivitamina D3 2-metilen-19-nor-1a-hidroxipregnacalciferol, 1a-hidroxi-2-metilen- 19-nor-homopregnacalciferol, (20R)-1a-hidroxi2-metilen-19-nor-bish omopregnacalciferol, 2-metilen-(20S)-19-nor-1a-hidroxitrishomopreg nacalciferol, 2-metilen-(20R)-23,23-difluoro-1a-hidroxi-19-nor-bis homopregnacalciferol, 2-metilen-(20S)-23,23-difluoro-1a-hidroxi-19 -nor-bishomopregnancalciferol, 2-(3´hidroxipropil-1´ ,2´-ideno)-19,23,24-trinor-(20S)-1a-hidroxivitamina D3, o análogo de 13,13 -dimetil-des-C,D de (20S)-2-metilen-1a, 25-dihidroxi-19-nor-vitamina D3, y formulaciones tópicas farmacéuticas y formas de dosis tópicas de las mismas que usan un vehículo portador farmacéuticamente adecuado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3440108P | 2008-03-06 | 2008-03-06 | |
| PCT/US2009/036323 WO2009111695A1 (en) | 2008-03-06 | 2009-03-06 | Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010009578A true MX2010009578A (es) | 2010-09-24 |
Family
ID=40750898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010009578A MX2010009578A (es) | 2008-03-06 | 2009-03-06 | Metodos para incrementar el espesor epidermico de la piel mediante la administracion topica de un compuesto de vitamina d que contiene 19-nor. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8143238B2 (es) |
| EP (1) | EP2262507A1 (es) |
| JP (1) | JP2011513428A (es) |
| AU (1) | AU2009221717A1 (es) |
| CA (1) | CA2715811A1 (es) |
| MX (1) | MX2010009578A (es) |
| WO (1) | WO2009111695A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201270226A1 (ru) * | 2009-08-14 | 2012-09-28 | БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи | Витамин d3 и его аналогии для лечения алопеции |
| EP2556054B1 (en) * | 2010-03-23 | 2017-09-27 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3 |
| AU2011232633B2 (en) * | 2010-03-23 | 2014-05-29 | Wisconsin Alumni Research Foundation | (20S)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22- dimethyl-1alpha,25-hydroxyvitamin D3 |
| US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6392071B1 (en) * | 1997-03-17 | 2002-05-21 | Wisconsin Alumni: Research Foundation | 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
| US6440953B1 (en) | 2000-09-08 | 2002-08-27 | Wisconsin Alumni Research Foundation | 1α-hydroxy-2-methylene-19-nor-homopregnacalciferol and its uses |
| ES2315426T3 (es) * | 2001-12-13 | 2009-04-01 | Wisconsin Alumni Research Foundation | (20s)-1alfa-hidroxi-2-metileno-19-nor-bishomopregnacalciferol y sus usos. |
| US6566352B1 (en) * | 2002-02-18 | 2003-05-20 | Wisconsin Alumni Research Foudation | 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| WO2005051323A2 (en) * | 2003-11-25 | 2005-06-09 | Wisconsin Alumni Research Foundation | Vitamin d analogs for obesity prevention and treatment |
| US8404667B2 (en) | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
| CA2588060A1 (en) * | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol |
| CA2588038A1 (en) | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20r)-1-.alpha.-hydroxy-bishomopregnacalciferol |
| WO2006057917A2 (en) | 2004-11-23 | 2006-06-01 | Fmc Corporation | Hemipteran 5ht1 receptor |
| AU2006213722B2 (en) | 2005-02-11 | 2011-09-22 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin-D2 |
| US7528122B2 (en) * | 2006-02-02 | 2009-05-05 | Wisconsin Alumni Research Foundation | Vitamin D analog—NEL, methods and uses thereof |
| CA2648193A1 (en) | 2006-04-05 | 2007-10-18 | Wisconsin Alumni Research Foundation | 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds and methods of making and use thereof |
-
2009
- 2009-03-06 WO PCT/US2009/036323 patent/WO2009111695A1/en active Application Filing
- 2009-03-06 CA CA2715811A patent/CA2715811A1/en not_active Abandoned
- 2009-03-06 MX MX2010009578A patent/MX2010009578A/es not_active Application Discontinuation
- 2009-03-06 US US12/399,070 patent/US8143238B2/en not_active Expired - Fee Related
- 2009-03-06 AU AU2009221717A patent/AU2009221717A1/en not_active Abandoned
- 2009-03-06 EP EP09717269A patent/EP2262507A1/en not_active Withdrawn
- 2009-03-06 JP JP2010549906A patent/JP2011513428A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009221717A1 (en) | 2009-09-11 |
| JP2011513428A (ja) | 2011-04-28 |
| EP2262507A1 (en) | 2010-12-22 |
| US8143238B2 (en) | 2012-03-27 |
| WO2009111695A1 (en) | 2009-09-11 |
| WO2009111695A8 (en) | 2009-10-15 |
| US20090227545A1 (en) | 2009-09-10 |
| CA2715811A1 (en) | 2009-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9901587B2 (en) | Topical film delivery system | |
| Mercadante | Pharmacotherapy for breakthrough cancer pain | |
| MX2009013574A (es) | Formas de dosificacion solidas o semisolidas de liberacion modificada. | |
| JP2008534482A (ja) | 局所用組成物およびその使用 | |
| MXPA06012960A (es) | Administracion transdermal de ficotoxinas. | |
| WO2004105694A3 (en) | Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs | |
| MX2009005339A (es) | Suspensiones analgesicas de liberacion modificada. | |
| ATE509616T1 (de) | Topische pharmazeutische und/oder cosmetische dosierungssysteme | |
| WO2007121913A3 (en) | Pharmaceutical solution formulations for pressurised metered dose inhalers | |
| EP3501546A3 (de) | Cystein-wirkstoff konjugate und ihre verwendung | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| WO2005065319A3 (en) | Generally linear effervescent oral fentanyl dosage form and methods of administering | |
| WO2007134292A3 (en) | Treprostinil administration using a metered dose inhaler | |
| AR062320A1 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
| WO2003039436A3 (es) | Composiciones farmaceuticas que contienen oxibutinina | |
| JP2010525050A5 (es) | ||
| MX344787B (es) | Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara. | |
| WO2005081742A3 (en) | Testosterone oral dosage formulations and associated methods | |
| NZ605469A (en) | Nalbuphine-based formulations and uses thereof | |
| EP2591769A3 (en) | Compounds, compositions, kits and methods of use to topically treat acne and other skin conditions by administering a 19-nor containing vitamin D analog. | |
| MX2010009578A (es) | Metodos para incrementar el espesor epidermico de la piel mediante la administracion topica de un compuesto de vitamina d que contiene 19-nor. | |
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| Hu et al. | Percutaneous absorption and brain distribution facilitation of borneol on tetramethylpyrazine in a microemulsion-based transdermal therapeutic system | |
| WO2004073622A3 (en) | Novel therapeutic method and compositions for topical administration | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |